Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the marketing of 20 of the tobacco company’s Zyn nicotine pouches.
The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.
In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches. The pouches, which are placed between the lip and gum, are tobacco-free but contain nicotine. They come in different strengths and a variety of flavors such as citrus, coffee, peppermint and berry.
Shares of Philip Morris International Inc. ($PM) rose more than 1% on Thursday after the US Food and Drug Administration (FDA) authorized marketing of its Zyn nicotine pouch products, lifting retail sentiment.
The Food and Drug Administration has authorized ZYN nicotine pouches, “making ZYN the first and only authorized nicotine pouch in the United
The Food and Drug Administration OK'd 10 Zyn flavors, including coffee, mint and menthol. It's the first time regulators have authorized sales of nicotine pouches, which are the fastest-growing segment of the U.S. tobacco market.
Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday morning. It is up 28% over the past 12 months.
Stefano Volpetti, President of Smoke-Free Inhalable Products and Consumer Officer at Philip Morris International (PMI), affirmed the company's dedica
These items have become popular in c-stores as traditional tobacco sales plunge, and their approval sets the stage for continued growth.
Zyn products will be allowed to stay on the market after federal health officials Thursday said the popular nicotine pouches can help adult smokers cut back or switch completely. The Food
The Food and Drug Administration issued marketing granted orders to 20 Zyn nicotine pouch products. The announcement on Thursday marks the first nicotine pouch product to be authorized by the FDA.
The authorization means pouches can be marketed to adults 21 or older but doesn’t mean the products are “FDA approved.”